RU96116162A - Derivatives of pyrrolopyrindine - Google Patents
Derivatives of pyrrolopyrindineInfo
- Publication number
- RU96116162A RU96116162A RU96116162/04A RU96116162A RU96116162A RU 96116162 A RU96116162 A RU 96116162A RU 96116162/04 A RU96116162/04 A RU 96116162/04A RU 96116162 A RU96116162 A RU 96116162A RU 96116162 A RU96116162 A RU 96116162A
- Authority
- RU
- Russia
- Prior art keywords
- group
- pyridazine
- propenyl
- pharmacologically acceptable
- acceptable salts
- Prior art date
Links
- YTJAMOLQXDNLJC-UHFFFAOYSA-N N1N=CC=C2N=CC=C21 Chemical class N1N=CC=C2N=CC=C21 YTJAMOLQXDNLJC-UHFFFAOYSA-N 0.000 claims 32
- 150000003839 salts Chemical class 0.000 claims 31
- 239000011780 sodium chloride Substances 0.000 claims 31
- -1 2-methylcyclopropylmethyl group Chemical group 0.000 claims 19
- 125000004435 hydrogen atoms Chemical group [H]* 0.000 claims 19
- 239000011737 fluorine Substances 0.000 claims 11
- 229910052731 fluorine Inorganic materials 0.000 claims 11
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 claims 11
- 125000000217 alkyl group Chemical group 0.000 claims 10
- 239000000460 chlorine Chemical group 0.000 claims 10
- 229910052801 chlorine Inorganic materials 0.000 claims 10
- ZAMOUSCENKQFHK-UHFFFAOYSA-N chlorine atom Chemical group [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims 10
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 10
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims 9
- 125000003118 aryl group Chemical group 0.000 claims 8
- 125000001153 fluoro group Chemical group F* 0.000 claims 8
- 229910052717 sulfur Chemical group 0.000 claims 8
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims 7
- 125000005843 halogen group Chemical group 0.000 claims 7
- 125000004430 oxygen atoms Chemical group O* 0.000 claims 7
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims 6
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 claims 6
- 125000000041 C6-C10 aryl group Chemical group 0.000 claims 6
- 125000003342 alkenyl group Chemical group 0.000 claims 6
- 125000004186 cyclopropylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C1([H])[H] 0.000 claims 6
- 150000001875 compounds Chemical class 0.000 claims 5
- 125000000753 cycloalkyl group Chemical group 0.000 claims 5
- 125000004786 difluoromethoxy group Chemical group [H]C(F)(F)O* 0.000 claims 5
- 125000002541 furyl group Chemical group 0.000 claims 5
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 5
- 125000004076 pyridyl group Chemical group 0.000 claims 5
- 125000004434 sulfur atoms Chemical group 0.000 claims 5
- 125000001544 thienyl group Chemical group 0.000 claims 5
- 125000006729 (C2-C5) alkenyl group Chemical group 0.000 claims 4
- 125000004973 1-butenyl group Chemical group C(=CCC)* 0.000 claims 4
- 125000006017 1-propenyl group Chemical group 0.000 claims 4
- 125000004974 2-butenyl group Chemical group C(C=CC)* 0.000 claims 4
- 125000006022 2-methyl-2-propenyl group Chemical group 0.000 claims 4
- ICTGSQARZKHWET-UHFFFAOYSA-N [(E)-prop-1-enyl]benzene Chemical group C=C[CH]C1=CC=CC=C1 ICTGSQARZKHWET-UHFFFAOYSA-N 0.000 claims 4
- 125000003545 alkoxy group Chemical group 0.000 claims 4
- 125000001164 benzothiazolyl group Chemical group S1C(=NC2=C1C=CC=C2)* 0.000 claims 4
- 125000004541 benzoxazolyl group Chemical group O1C(=NC2=C1C=CC=C2)* 0.000 claims 4
- 125000002883 imidazolyl group Chemical group 0.000 claims 4
- 125000002971 oxazolyl group Chemical group 0.000 claims 4
- 229910052760 oxygen Inorganic materials 0.000 claims 4
- 239000001301 oxygen Chemical group 0.000 claims 4
- MYMOFIZGZYHOMD-UHFFFAOYSA-N oxygen Chemical group O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 claims 4
- 125000000335 thiazolyl group Chemical group 0.000 claims 4
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 4
- 125000001494 2-propynyl group Chemical group [H]C#CC([H])([H])* 0.000 claims 3
- 125000001313 C5-C10 heteroaryl group Chemical group 0.000 claims 3
- 125000002947 alkylene group Chemical group 0.000 claims 3
- 125000000392 cycloalkenyl group Chemical group 0.000 claims 3
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 claims 3
- YCKRFDGAMUMZLT-UHFFFAOYSA-N fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 claims 3
- 125000004785 fluoromethoxy group Chemical group [H]C([H])(F)O* 0.000 claims 3
- 125000004216 fluoromethyl group Chemical group [H]C([H])(F)* 0.000 claims 3
- 229910052736 halogen Inorganic materials 0.000 claims 3
- 150000002367 halogens Chemical class 0.000 claims 3
- 125000005842 heteroatoms Chemical group 0.000 claims 3
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 3
- 229910052757 nitrogen Inorganic materials 0.000 claims 3
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims 3
- NINIDFKCEFEMDL-UHFFFAOYSA-N sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims 3
- 239000011593 sulfur Chemical group 0.000 claims 3
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 claims 2
- 125000001781 1,3,4-oxadiazolyl group Chemical group 0.000 claims 2
- 125000004520 1,3,4-thiadiazolyl group Chemical group 0.000 claims 2
- HNEGJTWNOOWEMH-UHFFFAOYSA-N 1-fluoropropane Chemical group [CH2]CCF HNEGJTWNOOWEMH-UHFFFAOYSA-N 0.000 claims 2
- 125000004206 2,2,2-trifluoroethyl group Chemical group [H]C([H])(*)C(F)(F)F 0.000 claims 2
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 claims 2
- 125000000304 alkynyl group Chemical group 0.000 claims 2
- 125000004429 atoms Chemical group 0.000 claims 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical group BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims 2
- 238000006243 chemical reaction Methods 0.000 claims 2
- 125000004981 cycloalkylmethyl group Chemical group 0.000 claims 2
- OAKJQQAXSVQMHS-UHFFFAOYSA-N hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 claims 2
- 125000001841 imino group Chemical group [H]N=* 0.000 claims 2
- 125000001624 naphthyl group Chemical group 0.000 claims 2
- 230000003647 oxidation Effects 0.000 claims 2
- 238000007254 oxidation reaction Methods 0.000 claims 2
- 125000003373 pyrazinyl group Chemical group 0.000 claims 2
- 125000002098 pyridazinyl group Chemical group 0.000 claims 2
- USFDBIGIWRXJLQ-UHFFFAOYSA-N 1-(cyclopropylmethyl)-2,3-dimethyl-7-phenylmethoxypyrrolo[2,3-d]pyridazine Chemical compound C=12N(CC3CC3)C(C)=C(C)C2=CN=NC=1OCC1=CC=CC=C1 USFDBIGIWRXJLQ-UHFFFAOYSA-N 0.000 claims 1
- QADWCDAEVLESHG-UHFFFAOYSA-N 1-(cyclopropylmethyl)-7-[(4-fluorophenyl)methoxy]-2,3-dimethylpyrrolo[2,3-d]pyridazine Chemical compound C=12N(CC3CC3)C(C)=C(C)C2=CN=NC=1OCC1=CC=C(F)C=C1 QADWCDAEVLESHG-UHFFFAOYSA-N 0.000 claims 1
- ZQVCXPORJIPTJT-UHFFFAOYSA-N 1-(cyclopropylmethyl)-7-[2-(4-fluorophenyl)ethyl]-2,3-dimethylpyrrolo[2,3-d]pyridazine Chemical compound C=12N(CC3CC3)C(C)=C(C)C2=CN=NC=1CCC1=CC=C(F)C=C1 ZQVCXPORJIPTJT-UHFFFAOYSA-N 0.000 claims 1
- FEBDACOHTVBFLB-UHFFFAOYSA-N 1-but-2-enyl-2,3-dimethyl-7-(2-phenylethyl)pyrrolo[2,3-d]pyridazine Chemical compound C=12N(CC=CC)C(C)=C(C)C2=CN=NC=1CCC1=CC=CC=C1 FEBDACOHTVBFLB-UHFFFAOYSA-N 0.000 claims 1
- APYJMPFHBAIIJU-UHFFFAOYSA-N 1-but-2-enyl-2,3-dimethyl-7-phenylmethoxypyrrolo[2,3-d]pyridazine Chemical compound C=12N(CC=CC)C(C)=C(C)C2=CN=NC=1OCC1=CC=CC=C1 APYJMPFHBAIIJU-UHFFFAOYSA-N 0.000 claims 1
- WHPRSSXXCMZXNM-UHFFFAOYSA-N 1-but-2-enyl-3-ethyl-7-[(4-fluorophenyl)methoxy]-2-methylpyrrolo[2,3-d]pyridazine Chemical compound N1=NC=C2C(CC)=C(C)N(CC=CC)C2=C1OCC1=CC=C(F)C=C1 WHPRSSXXCMZXNM-UHFFFAOYSA-N 0.000 claims 1
- UXVGZBIXIIZXOQ-UHFFFAOYSA-N 1-but-2-enyl-7-[(2,4-dichlorophenyl)methoxy]-2,3-dimethylpyrrolo[2,3-d]pyridazine Chemical compound C=12N(CC=CC)C(C)=C(C)C2=CN=NC=1OCC1=CC=C(Cl)C=C1Cl UXVGZBIXIIZXOQ-UHFFFAOYSA-N 0.000 claims 1
- ZMZYWEXDMXONSY-UHFFFAOYSA-N 1-but-2-enyl-7-[(2,4-difluorophenyl)methoxy]-2,3-dimethyl-5-oxidopyrrolo[2,3-d]pyridazin-5-ium Chemical compound C=12N(CC=CC)C(C)=C(C)C2=C[N+]([O-])=NC=1OCC1=CC=C(F)C=C1F ZMZYWEXDMXONSY-UHFFFAOYSA-N 0.000 claims 1
- IDIWCHKLJAZFMM-UHFFFAOYSA-N 1-but-2-enyl-7-[(2,4-difluorophenyl)methoxy]-2,3-dimethylpyrrolo[2,3-d]pyridazine Chemical compound C=12N(CC=CC)C(C)=C(C)C2=CN=NC=1OCC1=CC=C(F)C=C1F IDIWCHKLJAZFMM-UHFFFAOYSA-N 0.000 claims 1
- RIMLLRVAYHCKRC-UHFFFAOYSA-N 1-but-2-enyl-7-[(2,4-difluorophenyl)methylsulfanyl]-2,3-dimethylpyrrolo[2,3-d]pyridazine Chemical compound C=12N(CC=CC)C(C)=C(C)C2=CN=NC=1SCC1=CC=C(F)C=C1F RIMLLRVAYHCKRC-UHFFFAOYSA-N 0.000 claims 1
- CEKZETUBQDKQKA-UHFFFAOYSA-N 1-but-2-enyl-7-[(2-chloro-6-fluorophenyl)methoxy]-2,3-dimethylpyrrolo[2,3-d]pyridazine Chemical compound C=12N(CC=CC)C(C)=C(C)C2=CN=NC=1OCC1=C(F)C=CC=C1Cl CEKZETUBQDKQKA-UHFFFAOYSA-N 0.000 claims 1
- OTTJCBSOOXSILK-UHFFFAOYSA-N 1-but-2-enyl-7-[(4-chloro-2-fluorophenyl)methoxy]-2,3-dimethylpyrrolo[2,3-d]pyridazine Chemical compound C=12N(CC=CC)C(C)=C(C)C2=CN=NC=1OCC1=CC=C(Cl)C=C1F OTTJCBSOOXSILK-UHFFFAOYSA-N 0.000 claims 1
- OOHBUEABHBOJJQ-UHFFFAOYSA-N 1-but-2-enyl-7-[(4-fluorophenyl)methoxy]-2,3-dimethyl-5-oxidopyrrolo[2,3-d]pyridazin-5-ium Chemical compound C=12N(CC=CC)C(C)=C(C)C2=C[N+]([O-])=NC=1OCC1=CC=C(F)C=C1 OOHBUEABHBOJJQ-UHFFFAOYSA-N 0.000 claims 1
- KIUORNGKRGLROA-UHFFFAOYSA-N 1-but-2-enyl-7-[(4-fluorophenyl)methoxy]-2,3-dimethylpyrrolo[2,3-d]pyridazine Chemical compound C=12N(CC=CC)C(C)=C(C)C2=CN=NC=1OCC1=CC=C(F)C=C1 KIUORNGKRGLROA-UHFFFAOYSA-N 0.000 claims 1
- GQWAISYMVMPUJT-UHFFFAOYSA-N 1-but-2-enyl-7-[(4-fluorophenyl)methylsulfanyl]-2,3-dimethylpyrrolo[2,3-d]pyridazine Chemical compound C=12N(CC=CC)C(C)=C(C)C2=CN=NC=1SCC1=CC=C(F)C=C1 GQWAISYMVMPUJT-UHFFFAOYSA-N 0.000 claims 1
- CHAXZUWOAIXHMU-UHFFFAOYSA-N 1-but-2-enyl-7-[2-(2,4-difluorophenyl)ethyl]-2,3-dimethyl-5-oxidopyrrolo[2,3-d]pyridazin-5-ium Chemical compound C=12N(CC=CC)C(C)=C(C)C2=C[N+]([O-])=NC=1CCC1=CC=C(F)C=C1F CHAXZUWOAIXHMU-UHFFFAOYSA-N 0.000 claims 1
- BANSVOHTSGFJJX-UHFFFAOYSA-N 1-but-2-enyl-7-[2-(4-fluorophenyl)ethyl]-2,3-dimethylpyrrolo[2,3-d]pyridazine Chemical compound C=12N(CC=CC)C(C)=C(C)C2=CN=NC=1CCC1=CC=C(F)C=C1 BANSVOHTSGFJJX-UHFFFAOYSA-N 0.000 claims 1
- IFPHZQFVLFVKLI-UHFFFAOYSA-N 2,3-dimethyl-1-(2-methylprop-2-enyl)-7-phenylmethoxypyrrolo[2,3-d]pyridazine Chemical compound C=12N(CC(=C)C)C(C)=C(C)C2=CN=NC=1OCC1=CC=CC=C1 IFPHZQFVLFVKLI-UHFFFAOYSA-N 0.000 claims 1
- OFTROUGHZPGPDW-UHFFFAOYSA-N 2,3-dimethyl-1-[(2-methylcyclopropyl)methyl]-7-(2-phenylethyl)pyrrolo[2,3-d]pyridazine Chemical compound CC1CC1CN1C2=C(CCC=3C=CC=CC=3)N=NC=C2C(C)=C1C OFTROUGHZPGPDW-UHFFFAOYSA-N 0.000 claims 1
- HXFOUQHOORUXBU-UHFFFAOYSA-N 2,3-dimethyl-7-(2-phenylethyl)-1-prop-2-enylpyrrolo[2,3-d]pyridazine Chemical compound C=12N(CC=C)C(C)=C(C)C2=CN=NC=1CCC1=CC=CC=C1 HXFOUQHOORUXBU-UHFFFAOYSA-N 0.000 claims 1
- HLJNAZVBCOSFAA-UHFFFAOYSA-N 2,3-dimethyl-7-phenylmethoxy-1-prop-2-ynylpyrrolo[2,3-d]pyridazine Chemical compound C=12N(CC#C)C(C)=C(C)C2=CN=NC=1OCC1=CC=CC=C1 HLJNAZVBCOSFAA-UHFFFAOYSA-N 0.000 claims 1
- YSAVQFLCXQDXJC-UHFFFAOYSA-N 7-[(2,4-dichlorophenyl)methoxy]-2,3-dimethyl-1-prop-2-enylpyrrolo[2,3-d]pyridazine Chemical compound C=12N(CC=C)C(C)=C(C)C2=CN=NC=1OCC1=CC=C(Cl)C=C1Cl YSAVQFLCXQDXJC-UHFFFAOYSA-N 0.000 claims 1
- HNORUNBXDVOQJC-UHFFFAOYSA-N 7-[(2,4-difluorophenyl)methoxy]-2,3-dimethyl-1-[(2-methylcyclopropyl)methyl]pyrrolo[2,3-d]pyridazine Chemical compound CC1CC1CN1C2=C(OCC=3C(=CC(F)=CC=3)F)N=NC=C2C(C)=C1C HNORUNBXDVOQJC-UHFFFAOYSA-N 0.000 claims 1
- QDIQGIQRIPEDTK-UHFFFAOYSA-N 7-[(2,4-difluorophenyl)methoxy]-2,3-dimethyl-1-prop-2-enylpyrrolo[2,3-d]pyridazine Chemical compound C=12N(CC=C)C(C)=C(C)C2=CN=NC=1OCC1=CC=C(F)C=C1F QDIQGIQRIPEDTK-UHFFFAOYSA-N 0.000 claims 1
- VMFGTNOLRKEWNB-UHFFFAOYSA-N 7-[(2-fluorophenyl)methoxy]-2,3-dimethyl-1-prop-2-enylpyrrolo[2,3-d]pyridazine Chemical compound C=12N(CC=C)C(C)=C(C)C2=CN=NC=1OCC1=CC=CC=C1F VMFGTNOLRKEWNB-UHFFFAOYSA-N 0.000 claims 1
- ZZXGVNQRNOEQBV-UHFFFAOYSA-N 7-[(4-chlorophenyl)methoxy]-2,3-dimethyl-1-prop-2-enylpyrrolo[2,3-d]pyridazine Chemical compound C=12N(CC=C)C(C)=C(C)C2=CN=NC=1OCC1=CC=C(Cl)C=C1 ZZXGVNQRNOEQBV-UHFFFAOYSA-N 0.000 claims 1
- NXPLYKRKIFPEOA-UHFFFAOYSA-N 7-[(4-fluorophenyl)methoxy]-2,3-dimethyl-1-[(2-methylcyclopropyl)methyl]pyrrolo[2,3-d]pyridazine Chemical compound CC1CC1CN1C2=C(OCC=3C=CC(F)=CC=3)N=NC=C2C(C)=C1C NXPLYKRKIFPEOA-UHFFFAOYSA-N 0.000 claims 1
- XYWWGPRLAXSSKZ-UHFFFAOYSA-N 7-[(4-fluorophenyl)methoxy]-2,3-dimethyl-1-prop-1-enylpyrrolo[2,3-d]pyridazine Chemical compound C=12N(C=CC)C(C)=C(C)C2=CN=NC=1OCC1=CC=C(F)C=C1 XYWWGPRLAXSSKZ-UHFFFAOYSA-N 0.000 claims 1
- MZBYYTSYUWDHPO-UHFFFAOYSA-N 7-[(4-fluorophenyl)methoxy]-2,3-dimethyl-1-prop-2-enylpyrrolo[2,3-d]pyridazine Chemical compound C=12N(CC=C)C(C)=C(C)C2=CN=NC=1OCC1=CC=C(F)C=C1 MZBYYTSYUWDHPO-UHFFFAOYSA-N 0.000 claims 1
- XOKYGQZKRMWWLC-UHFFFAOYSA-N 7-[(4-fluorophenyl)methylsulfanyl]-2,3-dimethyl-1-prop-2-enylpyrrolo[2,3-d]pyridazine Chemical compound C=12N(CC=C)C(C)=C(C)C2=CN=NC=1SCC1=CC=C(F)C=C1 XOKYGQZKRMWWLC-UHFFFAOYSA-N 0.000 claims 1
- FFNUEVXGQQOPSU-UHFFFAOYSA-N 7-[2-(2,4-difluorophenyl)ethyl]-2,3-dimethyl-1-[(2-methylcyclopropyl)methyl]pyrrolo[2,3-d]pyridazine Chemical compound CC1CC1CN1C2=C(CCC=3C(=CC(F)=CC=3)F)N=NC=C2C(C)=C1C FFNUEVXGQQOPSU-UHFFFAOYSA-N 0.000 claims 1
- ZSNQOZPVTLLTAP-UHFFFAOYSA-N 7-[2-(2,4-difluorophenyl)ethyl]-2,3-dimethyl-1-prop-2-enylpyrrolo[2,3-d]pyridazine Chemical compound C=12N(CC=C)C(C)=C(C)C2=CN=NC=1CCC1=CC=C(F)C=C1F ZSNQOZPVTLLTAP-UHFFFAOYSA-N 0.000 claims 1
- ZRJMWGWSSWVIIL-UHFFFAOYSA-N 7-[2-(4-fluorophenyl)ethyl]-2,3-dimethyl-1-[(2-methylcyclopropyl)methyl]pyrrolo[2,3-d]pyridazine Chemical compound CC1CC1CN1C2=C(CCC=3C=CC(F)=CC=3)N=NC=C2C(C)=C1C ZRJMWGWSSWVIIL-UHFFFAOYSA-N 0.000 claims 1
- CYTQKIYUYPLICG-UHFFFAOYSA-N 7-[2-(4-fluorophenyl)ethyl]-2,3-dimethyl-1-prop-2-enylpyrrolo[2,3-d]pyridazine Chemical compound C=12N(CC=C)C(C)=C(C)C2=CN=NC=1CCC1=CC=C(F)C=C1 CYTQKIYUYPLICG-UHFFFAOYSA-N 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 claims 1
- 125000005037 alkyl phenyl group Chemical group 0.000 claims 1
- 239000003699 antiulcer agent Substances 0.000 claims 1
- 229910052804 chromium Chemical group 0.000 claims 1
- 239000011651 chromium Chemical group 0.000 claims 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N chromium Chemical group [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 claims 1
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 claims 1
Claims (31)
где R1 представляет собой C2-C6-алкенильную группу, галоген-C2-C6-алкенильную группу, (C6-C10арил-C2-C6алкенильную группу, C2-C6алкинильную группу, C3-C7циклоалкильную группу, (C3-C7циклоалкил)-C1-C6алкильную группу, (C5-C7циклоалкенил)-C1-C6алкильную группу или галоген-C1-C6алкильную группу;
R2 и R3 могут быть одинаковыми или различными, и каждый из них представляет собой атом водорода, C1-C6-алкильную группу, или C6-C10арильную группу;
R4 представляет собой атом водорода или C1-C6-алкильную группу;
R5 представляет собой C6-C10арильную группу или 5 - 10-членную гетероарильную группу, содержащую гетероатомы, выбранные из атомов азота, кислорода и серы;
A представляет собой C1-C3алкиленовую группу;
X представляет собой имино-группу, атом кислорода, атом серы или метиленовую группу;
m = 0 или 1;
n = 0 или 1;
или их фармакологически приемлемые соли.1. Pyrrolopyridazine derivatives having the general formula
where R 1 represents a C 2 -C 6 alkenyl group, a halo C 2 -C 6 alkenyl group, (a C 6 -C 10 aryl C 2 -C 6 alkenyl group, a C 2 -C 6 alkynyl group, C 3 -C 7 cycloalkyl group, (C 3 -C 7 cycloalkyl) -C 1 -C 6 alkyl group, (C 5 -C 7 cycloalkenyl) -C 1 -C 6 alkyl group or halogen-C 1 -C 6 alkyl group ;
R 2 and R 3 may be the same or different, and each of them represents a hydrogen atom, a C 1 -C 6 alkyl group, or a C 6 -C 10 aryl group;
R 4 represents a hydrogen atom or a C 1 -C 6 alkyl group;
R 5 is a C 6 -C 10 aryl group or a 5-10 membered heteroaryl group containing heteroatoms selected from nitrogen, oxygen and sulfur;
A represents a C 1 -C 3 alkylene group;
X represents an imino group, an oxygen atom, a sulfur atom or a methylene group;
m = 0 or 1;
n = 0 or 1;
or their pharmacologically acceptable salts.
1-(2-бутенил)-7-бензилокси-2,3-диметилпирроло[2,3-d]пиридазин;
7-бензилокси-2,3-диметил-1-(2-метил-2-пропенил)пирроло[2,3-d]пиридазин;
7-бензилокси-2,3-диметил-1-(2-пропинил)пирроло[2,3-d]пиридазин;
7-бензилокси-1-циклопропилметил-2,3-диметилпирроло[2,3-d]пиридазин;
7-(4-фторбензилокси)-2,3-диметил-1-(1-пропенил)пирроло[2,3-d]пиридазин;
7-(4-фторбензилокси)-2,3-диметил-1-(2-пропенил)пирроло[2,3-d]пиридазин;
1-(2-бутенил)-7-(4-фторбензилокси)-2,3-диметилпирроло[2,3-d]пиридазин;
1-циклопропилметил-7-(4-фторбензилокси)-2,3-диметилпирроло[2,3-d] пиридазин;
7-(2,4-дифторбензилокси)-2,3-диметил-1-(2-пропенил)пирроло[2,3-d] пиридазин;
1-(2-бутенил)-7-(2,4-дифторбензилокси)-2,3-диметилпирроло[2,3-d]пиридазин;
7-(4-хлорбензилокси)-2,3-диметил-1-(2-пропенил)пирроло[2,3-d]пиридазин;
7-(2,4-дихлорбензилокси)-2,3-диметил-1-(2-пропенил)пирроло[2,3-d] пиридазин;
1-(2-бутенил)-7-(2,4-дихлорбензилокси)-2,3-диметилпирроло[2,3-d]пиридазин;
7-(2-фторбензилокси)-2,3-диметил-1-(2-пропенил)пирроло[2,3-d]пиридазин;
1-(2-бутенил)-3-этил-7-(4-фторбензилокси)-2-метилпирроло[2,3-d] пиридазин;
7-(4-фторбензилтио)-2,3-диметил-1-(2-пропенил)пирроло[2,3-d]пиридазин;
1-(2-бутенил)-7-(4-фторбензилтио)-2,3-диметилпирроло[2,3-d]пиридазин;
1-(2-бутенил)-7-(2,4-дифторбензилтио)-2,3-диметилпирроло[2,3-d] пиридазин;
1-(2-бутенил)-7-(2-хлор-6-фторбензилокси)-2,3-диметилпирроло[2,3-d] пиридазин;
1-(2-бутенил)-7-(4-хлор-2-фторбензилокси)-2,3-диметилпирроло[2,3-d] пиридазин;
7-(4-фторбензилокси)-2,3-диметил-1-(2-метилциклопропилметил)пирроло[2,3-d]пиридазин;
7-(2,4-дифторбензилокси)-2,3-диметил-1-(2-метилциклопропилметил)пирроло [2,3-d]пиридазин;
2,3-диметил-7-фенетил-1-(2-пропенил)пирроло[2,3-d]пиридазин;
1-(2-бутенил)-2,3-диметил-7-фенетилпирроло[2,3-d]пиридазин;
7-(4-фторфенетил)-2,3-диметил-1-(2-пропенил)пирроло[2,3-d]пиридазин;
1-(2-бутенил)-7-(4-фторфенетил)-2,3-диметилпирроло[2,3-d]пиридазин;
1-циклопропилметил-7-(4-фторфенетил)-2,3-диметилпирроло[2,3-d]пиридазин;
7-(2,4-дифторфенетил)-2,3-диметил-1-(2-пропенил)пирроло[2,3-d]пиридазин;
1-(2-бутенил)-7-(2,4-дифторфенетил)-2,3-диметилпирроло[2,3-d]пиридазин;
1-циклопропилметил-7-(2,4-дифторфенетил)-2,3-диметилпирроло[2,3-d] пиридазин;
7-(4-фторфенетил)-2,3-диметил-1-(2-метилциклопропилметил)пирроло[2,3-d] пиридазин;
7-(2,4-дифторфенетил)-2,3-диметил-1-(2-метилциклопропилметил)пирроло[2,3-d]пиридазин;
2,3-диметил-1-(2-метилциклопропилметил)-7-фенетилпирроло[2,3-d] пиридазин;
1-(2-бутенил)-7-(4-фторбензилокси)-2,3-диметилпирроло[2,3-d] пиридазин-5-оксид;
1-(2-бутенил)-7-(2,4-дифторбензилокси)-2,3-диметилпирроло[2,3-d] пиридазин-5-оксид;
1-(2-бутенил)-7-(2,4-дифторфенетил)-2,3-диметилпирроло[2,3-d] пиридазин-5-оксид; и
1-(2-бутенил)-7-(2,4-дифторфенетил)-2,3-диметилпирроло[2,3-d] пиридазин-6-оксид.28. Pyrrolopyridazine derivatives or their pharmacologically acceptable salts according to claim 1, wherein said pyrrolopyridazine derivatives are selected from the following compounds:
1- (2-butenyl) -7-benzyloxy-2,3-dimethylpyrrolo [2,3-d] pyridazine;
7-benzyloxy-2,3-dimethyl-1- (2-methyl-2-propenyl) pyrrolo [2,3-d] pyridazine;
7-benzyloxy-2,3-dimethyl-1- (2-propynyl) pyrrolo [2,3-d] pyridazine;
7-benzyloxy-1-cyclopropylmethyl-2,3-dimethylpyrrolo [2,3-d] pyridazine;
7- (4-Fluorobenzyloxy) -2,3-dimethyl-1- (1-propenyl) pyrrolo [2,3-d] pyridazine;
7- (4-Fluorobenzyloxy) -2,3-dimethyl-1- (2-propenyl) pyrrolo [2,3-d] pyridazine;
1- (2-butenyl) -7- (4-fluorobenzyloxy) -2,3-dimethylpyrrolo [2,3-d] pyridazine;
1-cyclopropylmethyl-7- (4-fluorobenzyloxy) -2,3-dimethylpyrrolo [2,3-d] pyridazine;
7- (2,4-difluorobenzyloxy) -2,3-dimethyl-1- (2-propenyl) pyrrolo [2,3-d] pyridazine;
1- (2-butenyl) -7- (2,4-difluorobenzyloxy) -2,3-dimethylpyrrolo [2,3-d] pyridazine;
7- (4-chlorobenzyloxy) -2,3-dimethyl-1- (2-propenyl) pyrrolo [2,3-d] pyridazine;
7- (2,4-dichlorobenzyloxy) -2,3-dimethyl-1- (2-propenyl) pyrrolo [2,3-d] pyridazine;
1- (2-butenyl) -7- (2,4-dichlorobenzyloxy) -2,3-dimethylpyrrolo [2,3-d] pyridazine;
7- (2-Fluorobenzyloxy) -2,3-dimethyl-1- (2-propenyl) pyrrolo [2,3-d] pyridazine;
1- (2-butenyl) -3-ethyl-7- (4-fluorobenzyloxy) -2-methylpyrrolo [2,3-d] pyridazine;
7- (4-fluoro-benzylthio) -2,3-dimethyl-1- (2-propenyl) pyrrolo [2,3-d] pyridazine;
1- (2-butenyl) -7- (4-fluorobenzylthio) -2,3-dimethylpyrrolo [2,3-d] pyridazine;
1- (2-butenyl) -7- (2,4-difluorobenzylthio) -2,3-dimethylpyrrolo [2,3-d] pyridazine;
1- (2-butenyl) -7- (2-chloro-6-fluorobenzyloxy) -2,3-dimethylpyrrolo [2,3-d] pyridazine;
1- (2-butenyl) -7- (4-chloro-2-fluorobenzyloxy) -2,3-dimethylpyrrolo [2,3-d] pyridazine;
7- (4-Fluorobenzyloxy) -2,3-dimethyl-1- (2-methylcyclopropylmethyl) pyrrolo [2,3-d] pyridazine;
7- (2,4-difluorobenzyloxy) -2,3-dimethyl-1- (2-methylcyclopropylmethyl) pyrrolo [2,3-d] pyridazine;
2,3-dimethyl-7-phenethyl-1- (2-propenyl) pyrrolo [2,3-d] pyridazine;
1- (2-butenyl) -2,3-dimethyl-7-phenethylpyrrolo [2,3-d] pyridazine;
7- (4-fluorophenethyl) -2,3-dimethyl-1- (2-propenyl) pyrrolo [2,3-d] pyridazine;
1- (2-butenyl) -7- (4-fluorophenethyl) -2,3-dimethylpyrrolo [2,3-d] pyridazine;
1-cyclopropylmethyl-7- (4-fluorophenethyl) -2,3-dimethylpyrrolo [2,3-d] pyridazine;
7- (2,4-difluorophenethyl) -2,3-dimethyl-1- (2-propenyl) pyrrolo [2,3-d] pyridazine;
1- (2-butenyl) -7- (2,4-difluorophenyl) -2,3-dimethylpyrrolo [2,3-d] pyridazine;
1-cyclopropylmethyl-7- (2,4-difluorophenyl) -2,3-dimethylpyrrolo [2,3-d] pyridazine;
7- (4-fluorophenethyl) -2,3-dimethyl-1- (2-methylcyclopropylmethyl) pyrrolo [2,3-d] pyridazine;
7- (2,4-difluorophenethyl) -2,3-dimethyl-1- (2-methylcyclopropylmethyl) pyrrolo [2,3-d] pyridazine;
2,3-dimethyl-1- (2-methylcyclopropylmethyl) -7-phenethylpyrrolo [2,3-d] pyridazine;
1- (2-butenyl) -7- (4-fluorobenzyloxy) -2,3-dimethylpyrrolo [2,3-d] pyridazine-5-oxide;
1- (2-butenyl) -7- (2,4-difluorobenzyloxy) -2,3-dimethylpyrrolo [2,3-d] pyridazine-5-oxide;
1- (2-butenyl) -7- (2,4-difluorophenethyl) -2,3-dimethylpyrrolo [2,3-d] pyridazine-5-oxide; and
1- (2-butenyl) -7- (2,4-difluorophenyl) -2,3-dimethylpyrrolo [2,3-d] pyridazin-6-oxide.
где R1, R2, R3, R4, R5, A и Xa являются такими, как они определены ниже;
m = 0 или 1;
n = 0 или 1,
или их фармакологически приемлемых солей, отличающийся тем, что осуществляют реакцию соединения общей формулы II
где R1 представляет собой C2-C6-алкенильную группу, галоген-C2-C6алкенильную группу, (C6-C10арил)-C2-C6алкенильную группу, C2-C6алкинильную группу, C3-C7-циклоалкильную группу, (C3-C7циклоалкил)-C1-C6-алкильную группу, (C5-C7-циклоалкенил)-C1-C6-алкильную группу или галоген-C1-C6-алкильную группу;
R2 и R3 являются одинаковыми или различными, и каждый из них представляет собой атом водорода, C1-C6-алкильную группу или C6-C10арильную группу;
R4 представляет собой атом водорода или C1-C6-алкильную группу;
Y представляет собой атом галогена,
с соединением общей формулы III
R5 - A - Xa - H,
где R5 представляет собой C6-C10арильную группу или 5 - 10-членную гетероарильную группу, содержащую гетероатомы, выбранные из атомов азота, кислорода и серы;
A представляет собой C1-C3-алкиленовую группу;
Xa представляет собой имино-группу, атом кислорода или атом серы,
в присутствии или в отсутствие основания, и, если это необходимо, с последующим окислением полученного продукта.30. The method of obtaining pyrrolopyridazine derivatives having the general formula
where R 1 , R 2 , R 3 , R 4 , R 5 , A and Xa are as defined below;
m = 0 or 1;
n = 0 or 1,
or their pharmacologically acceptable salts, characterized in that they carry out the reaction of compounds of General formula II
where R 1 represents a C 2 -C 6 alkenyl group, a halo C 2 -C 6 alkenyl group, (C 6 -C 10 aryl) C 2 -C 6 alkenyl group, a C 2 -C 6 alkynyl group, C 3 -C 7 -cycloalkyl group, (C 3 -C 7 cycloalkyl) -C 1 -C 6 alkyl group, (C 5 -C 7 cycloalkenyl) -C 1 -C 6 alkyl group or halogen-C 1 - C 6 is an alkyl group;
R 2 and R 3 are the same or different, and each of them represents a hydrogen atom, a C 1 -C 6 alkyl group or a C 6 -C 10 aryl group;
R 4 represents a hydrogen atom or a C 1 -C 6 alkyl group;
Y represents a halogen atom,
with a compound of general formula III
R 5 - A - Xa - H,
where R 5 represents a C 6 -C 10 aryl group or a 5-10 membered heteroaryl group containing heteroatoms selected from nitrogen, oxygen and sulfur;
A represents a C 1 -C 3 alkylene group;
Xa is an imino group, an oxygen atom or a sulfur atom,
in the presence or in the absence of a base, and, if necessary, followed by oxidation of the resulting product.
где R1, R2, R3, R4, R5, R6 и A являются такими, как они определены ниже;
m = 0 или 1;
n = 0 или 1;
или их фармакологически приемлемых солей, отличающийся тем, что осуществляют реакцию соединения общей формулы VI
где R1 представляет собой C2-C6-алкенильную группу, галоген-C2-C6-алкенильную группу, (C6-C10арил)-C2-C6 алкенильную группу, C3-C7циклоалкильную группу, (C3-C7циклоалкил)-C1-C6алкильную группу, (C5-C7циклоалкенил)-C1-C6 алкильную группу, или галоген-C1-C6 алкильную группу, или C2-C6алкильную группу;
R2 и R3 являются одинаковыми или различными, и каждый из них представляет собой атом водорода, C1-C6-алкильную группу или C6-C10 арильную группу;
R4 представляет собой атом водорода или C1-C6-алкильную группу;
R5 представляет собой C6-C10арильную группу или 5 - 10-членную гетероарильную группу, содержащую гетероатомы, выбранные из атомов азота, кислорода и серы;
A представляет собой C1-C3-алкиленовую группу;
Y представляет собой атом галогена,
с гидразином или его гидратом, и, если необходимо, с последующим окислением полученного продукта.31. The method of obtaining pyrrolopyridazine derivatives having the general formula
where R 1 , R 2 , R 3 , R 4 , R 5 , R 6 and A are as defined below;
m = 0 or 1;
n = 0 or 1;
or their pharmacologically acceptable salts, characterized in that they carry out the reaction of compounds of General formula VI
where R 1 represents a C 2 -C 6 alkenyl group, a halo C 2 -C 6 alkenyl group, a (C 6 -C 10 aryl) C 2 -C 6 alkenyl group, a C 3 -C 7 cycloalkyl group, (C 3 -C 7 cycloalkyl) -C 1 -C 6 alkyl group, (C 5 -C 7 cycloalkenyl) -C 1 -C 6 alkyl group, or halogen-C 1 -C 6 alkyl group, or C 2 -C 6 alkyl group;
R 2 and R 3 are the same or different, and each of them represents a hydrogen atom, a C 1 -C 6 alkyl group or a C 6 -C 10 aryl group;
R 4 represents a hydrogen atom or a C 1 -C 6 alkyl group;
R 5 is a C 6 -C 10 aryl group or a 5-10 membered heteroaryl group containing heteroatoms selected from nitrogen, oxygen and sulfur;
A represents a C 1 -C 3 alkylene group;
Y represents a halogen atom,
with hydrazine or its hydrate, and, if necessary, followed by oxidation of the resulting product.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP06-3988 | 1994-01-19 | ||
JP398894 | 1994-01-19 | ||
PCT/JP1995/000038 WO1995019980A1 (en) | 1994-01-19 | 1995-01-18 | Pyrrolopyridazine derivative |
Publications (2)
Publication Number | Publication Date |
---|---|
RU96116162A true RU96116162A (en) | 1998-12-10 |
RU2146257C1 RU2146257C1 (en) | 2000-03-10 |
Family
ID=11572411
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU96116162A RU2146257C1 (en) | 1994-01-19 | 1995-01-18 | Derivatives of pyrrolopyridazine, methods of their synthesis, antiulcer agent |
Country Status (19)
Country | Link |
---|---|
US (1) | US6063782A (en) |
EP (1) | EP0742218B1 (en) |
KR (1) | KR100361199B1 (en) |
CN (1) | CN1044811C (en) |
AT (1) | ATE229020T1 (en) |
AU (1) | AU680998B2 (en) |
CZ (1) | CZ283216B6 (en) |
DE (1) | DE69529056T2 (en) |
DK (1) | DK0742218T3 (en) |
ES (1) | ES2185693T3 (en) |
FI (1) | FI112488B (en) |
HK (1) | HK1015609A1 (en) |
HU (1) | HU225920B1 (en) |
MX (1) | MX9602850A (en) |
NO (1) | NO307300B1 (en) |
NZ (1) | NZ278675A (en) |
PT (1) | PT742218E (en) |
RU (1) | RU2146257C1 (en) |
WO (1) | WO1995019980A1 (en) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6316429B1 (en) * | 1997-05-07 | 2001-11-13 | Sugen, Inc. | Bicyclic protein kinase inhibitors |
SE9704404D0 (en) * | 1997-11-28 | 1997-11-28 | Astra Ab | New compounds |
DE19836698A1 (en) * | 1998-08-13 | 2000-02-17 | Bayer Ag | Process for the preparation of fluorinated benzyl alcohols and aldehydes |
TWI287014B (en) | 1999-06-15 | 2007-09-21 | Sankyo Co | Optically active pyrrolopyridazine compound |
CA2399380A1 (en) | 2000-02-10 | 2001-08-16 | Sankyo Company, Limited | Pyrrolopyridazine compound |
FR2849025B1 (en) * | 2002-12-20 | 2005-10-14 | Rhodia Chimie Sa | DIFLUOROMETHYLENE SUBSTITUTED ALLYL ESTERS, PROCESS FOR THEIR SYNTHESIS AND USE THEREOF |
JP2003119140A (en) * | 2001-08-08 | 2003-04-23 | Sankyo Co Ltd | Pharmaceutical agent containing pyrrolopyridazine compound |
WO2003026421A1 (en) * | 2001-09-27 | 2003-04-03 | Monsanto Technology, Llc | Fungicidal compositions and their applications in agriculture |
AU2003266622A1 (en) * | 2002-09-25 | 2004-04-19 | Sankyo Company, Limited | Medicinal composition for inhibiting increase in blood gastrin concentration |
WO2004029057A1 (en) * | 2002-09-25 | 2004-04-08 | Sankyo Company, Limited | Medicinal composition for treatment for or prevention of visceral pain |
EP1611901B1 (en) * | 2003-03-13 | 2013-07-10 | Eisai R&D Management Co., Ltd. | Preventive or remedy for teeth grinding |
CA2578880C (en) * | 2004-09-03 | 2013-01-29 | Yuhan Corporation | Pyrrolo[3,2-c]pyridine derivatives and processes for the preparation thereof |
ES2426920T3 (en) * | 2004-09-03 | 2013-10-25 | Yuhan Corporation | Pyrrolo [3,2-B] pyridine derivatives and processes for their preparation |
DE602005020957D1 (en) * | 2004-09-03 | 2010-06-10 | Yuhan Corp | PYRROLOE3,2-CYPYRIDINE DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF |
KR101137168B1 (en) * | 2005-03-09 | 2012-04-19 | 주식회사유한양행 | Pyrrolo[2,3-d]pyridazine derivatives and processes for the preparation thereof |
ES2383969T3 (en) * | 2006-01-16 | 2012-06-27 | Ube Industries, Ltd. | Pyrrolopyridazinone compound as PDE4 inhibitor |
CN101003537A (en) * | 2006-01-17 | 2007-07-25 | 上海恒瑞医药有限公司 | Derivative in pyrrolopyridazine category, preparation method, and application |
KR20120117905A (en) | 2010-01-28 | 2012-10-24 | 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 | Compositions and methods for enhancing proteasome activity |
SI2707101T1 (en) * | 2011-05-12 | 2019-06-28 | Proteostasis Therapeutics, Inc. | Proteostasis regulators |
US9849135B2 (en) | 2013-01-25 | 2017-12-26 | President And Fellows Of Harvard College | USP14 inhibitors for treating or preventing viral infections |
WO2015073528A1 (en) | 2013-11-12 | 2015-05-21 | Proteostasis Therapeutics, Inc. | Proteasome activity enhancing compounds |
CN107207431B (en) * | 2015-01-13 | 2021-02-09 | 维夫雷昂生物科学有限责任公司 | Ca2+Release of activated Ca2+Modulators of (CRAC) channels and pharmaceutical uses thereof |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8901430D0 (en) * | 1989-01-23 | 1989-03-15 | Smithkline Beckman Intercredit | Compounds |
IL97931A0 (en) * | 1990-04-27 | 1992-06-21 | Byk Gulden Lomberg Chem Fab | Pyridazine derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same |
US5068332A (en) * | 1990-10-12 | 1991-11-26 | American Home Products Corporation | Alkylidene analogs of 1'-aminospiro[isoquinoline-4(1H),3'-pyrrolidine]-1,2',3,5'(2H)-tetrones useful as aldose reductase inhibitors |
WO1992006979A1 (en) * | 1990-10-15 | 1992-04-30 | Byk Gulden Lomberg Chemische Fabrik Gmbh | New diazines |
EP0609328B1 (en) * | 1991-10-25 | 1999-04-28 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Pyrrolo-pyridazines with gastro-intestinal protective action |
-
1995
- 1995-01-18 PT PT95906477T patent/PT742218E/en unknown
- 1995-01-18 DE DE69529056T patent/DE69529056T2/en not_active Expired - Fee Related
- 1995-01-18 AT AT95906477T patent/ATE229020T1/en not_active IP Right Cessation
- 1995-01-18 NZ NZ278675A patent/NZ278675A/en unknown
- 1995-01-18 WO PCT/JP1995/000038 patent/WO1995019980A1/en active IP Right Grant
- 1995-01-18 MX MX9602850A patent/MX9602850A/en not_active IP Right Cessation
- 1995-01-18 CN CN95192061A patent/CN1044811C/en not_active Expired - Fee Related
- 1995-01-18 HU HU9601967A patent/HU225920B1/en not_active IP Right Cessation
- 1995-01-18 KR KR1019960703911A patent/KR100361199B1/en not_active IP Right Cessation
- 1995-01-18 ES ES95906477T patent/ES2185693T3/en not_active Expired - Lifetime
- 1995-01-18 AU AU14657/95A patent/AU680998B2/en not_active Ceased
- 1995-01-18 RU RU96116162A patent/RU2146257C1/en not_active IP Right Cessation
- 1995-01-18 CZ CZ962084A patent/CZ283216B6/en not_active IP Right Cessation
- 1995-01-18 DK DK95906477T patent/DK0742218T3/en active
- 1995-01-18 EP EP95906477A patent/EP0742218B1/en not_active Expired - Lifetime
-
1996
- 1996-07-17 US US08/676,375 patent/US6063782A/en not_active Expired - Fee Related
- 1996-07-18 NO NO962998A patent/NO307300B1/en unknown
- 1996-07-18 FI FI962892A patent/FI112488B/en active
-
1998
- 1998-12-01 HK HK98112609A patent/HK1015609A1/en not_active IP Right Cessation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU96116162A (en) | Derivatives of pyrrolopyrindine | |
Siddiqui et al. | Synthesis, anticonvulsant and toxicity evaluation of 2-(1H-indol-3-ylacetyl)-N-(substituted phenyl) hydrazinecarbothioamides and their related heterocyclic derivatives | |
RU96123129A (en) | DERIVATIVES OF ERYTHROMYCIN, METHOD FOR PRODUCING THEM AND THEIR APPLICATION AS MEDICINES | |
RU2004106554A (en) | NEW 1,2,4-TRIAZOLE COMPOUNDS | |
RU98107259A (en) | NEW DERIVATIVES OF PYRIDACARBOXYLIC ACID OR THEIR SALTS AND ANTIBACTERIAL PRODUCTS CONTAINING SUCH COMPOUNDS AS ACTIVE COMPONENTS | |
CA2251636A1 (en) | Process for the preparation of a magnesium salt of a substituted sulphinyl heterocycle | |
EP0355049A3 (en) | Heterocyclic compounds | |
JP2001525317A (en) | Metallization of macrocycles with 2,4-dicarbonyl metal complexes | |
RU2000104513A (en) | N-SULPHONYLGYLICINALKINYLOXYPHENETHYLAMIDE DERIVATIVES HAVING BACTERICIDAL ACTIVITY | |
EP0104690A3 (en) | Fungicidally active compositions containing ethene derivatives | |
PT77758A (en) | Process for the preparation of fungicidal compositions contai- ning substituted hydroxyalkyl-azoles | |
RU2001117070A (en) | Derivatives of dibenzene [a, g] quinolysinium and their salts | |
RU2005131735A (en) | CHEMICAL COMPOUNDS | |
HRP940364B1 (en) | Beta-aminovinyl ketones, preparation method therefor and use thereof for preparing beta diketones | |
KR100969178B1 (en) | Process for production of high-purity enamines | |
KR890003765A (en) | Imidazo benzodiazepines and their acid addition salts | |
RU2001128426A (en) | The method of obtaining 3S-3-amino-3-arylpropionic acid and its derivatives | |
HU910469D0 (en) | Fungicide preparatives containing 3-substituted pyridine-methanoles as active substance and process for producing the active substances | |
Schneider et al. | Host-guest chemistry. Part 30. Salt effects on supramolecular complexation and catalysis | |
PT70027A (en) | SUBSTITUTED N-PYRAZOLYLMETHYL HALOGENACETANILIDES PROCESS FOR THEIR PREPARATION AND HERBICIDES | |
JPS6046116B2 (en) | Method for producing substituted cephalosporins | |
RU2203893C2 (en) | Acrylonitrile compound or its salt, method of its synthesis, miticide, insecticide and agent containing above- mentioned compound for control of overgrowing with marine organisms, methods of control of insects, mites and marine organisms | |
Inoue et al. | The partition coefficient of aminouracil derivatives | |
KR940009153A (en) | Intermediate compounds for the preparation of antifolate compounds and preparation methods thereof | |
KR920021562A (en) | 3-pyrazine derivative substituted cephalosporin compound |